Raltegravir and rifampicin in patients with HIV and tuberculosis

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	1046-1047
Number of pages	2
Journal	The Lancet. Infectious diseases
Volume	14
Issue number	11
DOIs	https://doi.org/10.1016/s1473-3099(14)70977-6
Publication status	Published - 1 Nov 2014
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{56ed2e9348a640cfac7e45151153ff34,

title = "Raltegravir and rifampicin in patients with HIV and tuberculosis",

author = "Sandor Klis and Alper Daskapan and Akkerman, \{Onno W.\} and Alffenaar, \{Jan Willem\} and Ymkje Stienstra",

year = "2014",

month = nov,

day = "1",

doi = "10.1016/s1473-3099(14)70977-6",

language = "English",

volume = "14",

pages = "1046--1047",

journal = "The Lancet. Infectious diseases",

number = "11",

}

TY - JOUR

T1 - Raltegravir and rifampicin in patients with HIV and tuberculosis

AU - Klis, Sandor

AU - Daskapan, Alper

AU - Akkerman, Onno W.

AU - Alffenaar, Jan Willem

AU - Stienstra, Ymkje

PY - 2014/11/1

Y1 - 2014/11/1

U2 - 10.1016/s1473-3099(14)70977-6

DO - 10.1016/s1473-3099(14)70977-6

M3 - Letter

VL - 14

SP - 1046

EP - 1047

JO - The Lancet. Infectious diseases

JF - The Lancet. Infectious diseases

IS - 11

ER -